United States · FDA National Drug Code directory
CYRAMZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-7678_161cb5e7-7955-45e5-bdde-9be94fdbe76a
- Product NDC
- 0002-7678
- Form
- SOLUTION
- Composition / generic term
- ramucirumab
- Labeler
- Eli Lilly and Company
- Marketing category
- BLA
- Marketing start / end (source format)
- 20140421
- Source listing expiry
- 20271231
Source-listed ingredients
- RAMUCIRUMAB — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7678-01) / 50 mL in 1 VIAL, SINGLE-DOSE · 0002-7678-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →